http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108707672-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
filingDate | 2018-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108707672-B |
titleOfInvention | Application of DUXAP8 in diagnosis and treatment of hepatocellular carcinoma |
abstract | The invention discloses application of DUXAP8 in diagnosis and treatment of hepatocellular carcinoma, and the invention firstly discovers that the expression of DUXAP8 is up-regulated in a hepatocellular carcinoma patient, and verifies that DUXAP8 can be used as a detection target to be applied to auxiliary diagnosis of hepatocellular carcinoma through a large sample. The invention also discovers that DUXAP8 is related to proliferation, migration and invasion of liver cancer cells, and prompts that DUXAP8 can be used as a drug target to be applied to treatment of hepatocellular carcinoma and hepatocellular carcinoma invasion and metastasis. |
priorityDate | 2018-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 234.